ALBANESE, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 412
EU - Europa 203
AS - Asia 80
SA - Sud America 2
Totale 697
Nazione #
US - Stati Uniti d'America 412
IT - Italia 153
SG - Singapore 33
CN - Cina 30
ID - Indonesia 12
DE - Germania 10
PL - Polonia 8
CZ - Repubblica Ceca 7
SE - Svezia 7
GB - Regno Unito 6
RU - Federazione Russa 5
IE - Irlanda 4
CO - Colombia 2
FI - Finlandia 2
HK - Hong Kong 2
VN - Vietnam 2
IL - Israele 1
PT - Portogallo 1
Totale 697
Città #
Ferrara 81
Fairfield 53
Ashburn 47
Woodbridge 37
New York 34
Chandler 27
Seattle 27
Houston 22
Singapore 21
Shanghai 20
Cambridge 18
Milan 14
Princeton 13
Jakarta 12
Los Angeles 9
Wilmington 9
San Diego 8
Warsaw 8
Bologna 7
Ferrara di Monte Baldo 6
Addison 5
Ann Arbor 5
Brno 5
Dearborn 5
Falls Church 5
Padova 5
Boardman 4
Dublin 4
Grassano 4
Jena 4
Turin 4
Napoli 3
Beijing 2
Bogotá 2
Bremen 2
Catania 2
Dong Ket 2
Frankfurt am Main 2
Hong Kong 2
Olomouc 2
Prescot 2
Rome 2
Torino 2
Treviso 2
Augusta 1
Beirã 1
Chiswick 1
Hefei 1
Helsinki 1
Islington 1
Jerusalem 1
Lappeenranta 1
Leawood 1
London 1
Mountain View 1
Ningbo 1
Redmond 1
San Lazzaro di Savena 1
San Mateo 1
Sanming 1
Trento 1
Washington 1
Totale 568
Nome #
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 98
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 93
Synthesis and Biological Activity of Peptide α-Ketoamide Derivatives as Proteasome Inhibitors 91
Cu(II) coordination to His-containing linear peptides and related branched ones: Equalities and diversities 68
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 43
Novel Mixed NOP/Opioid Receptor Peptide Agonists 39
Impaired Priming of SARS-CoV-2-Specific Naive CD8+ T Cells in Older Subjects 38
Use of a Novel Peptide Welding Technology Platform for the Development of B- and T-Cell Epitope-Based Vaccines 37
Synthesis of 2,6-Dimethyltyrosine-Like Amino Acids through Pinacolinamide-Enabled C-H Dimethylation of 4-Dibenzylamino Phenylalanine 31
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 27
Thermodynamic Stability and Speciation of Ga(III) and Zr(IV) Complexes with High-Denticity Hydroxamate Chelators 26
Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer 24
Identification of small-molecule urea derivatives as PTPC modulators targeting the c subunit of F1/Fo-ATP synthase 24
Ageing Curtails the Diversity and Functionality of Nascent CD8+ T Cell Responses against SARS-CoV-2 24
Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide 21
(L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky ‘Forced-Traceless’ Regioselective Pd-Catalyzed C(sp2)–H Activation 17
Dimeric ferulic acid conjugate as a prodrug for brain targeting after nasal administration of loaded solid lipid microparticles 15
Non-neuronal TRPA1 encodes mechanical allodynia associated with neurogenic inflammation and partial nerve injury in rats 13
Impact of C- and N-terminal protection on the stability, metal chelation and antimicrobial properties of calcitermin 9
Bifunctional octadentate pseudopeptides as Zirconium-89 chelators for immuno-PET applications 8
Schwann cell insulin-like growth factor receptor type-1 mediates metastatic bone cancer pain in mice 7
How terminal protection affects the chemical and biological properties of the antimicrobial calcitermin 2
Totale 755
Categoria #
all - tutte 6.238
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.238


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 3 1 5 8 11 19 11 11 7 3 2
2020/2021151 7 1 12 1 3 23 38 10 7 20 7 22
2021/2022114 5 8 2 9 4 9 4 3 19 9 8 34
2022/2023115 10 9 4 9 10 3 18 17 16 1 13 5
2023/2024247 15 20 8 12 17 56 19 14 14 6 20 46
2024/202544 26 18 0 0 0 0 0 0 0 0 0 0
Totale 755